Trevena Announces Positive Topline OLINVYK Cognitive Function Data and Provides General Business Update PressReach · Aug 1, 2022
Quoin Pharmaceuticals Announces Receipt of Constructive Scientific Advice from EMA for QRX003 Development in Europe PressReach · Aug 1, 2022
Evofem Biosciences to Report Second Quarter 2022 Results and Provide Corporate Update on Thursday, August 4, 2022 PressReach · Aug 1, 2022
GeoVax Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate Against Sudan Ebolavirus Showing 100% Protection With a Single Immunization PressReach · Aug 1, 2022
Evoke Pharma Recognizes Gastroparesis Awareness Month through its Support of The International Foundation for Gastrointestinal Disorders (IFFGD) PressReach · Aug 1, 2022
Evofem Biosciences Discusses Innovative Woman-Controlled Contraceptive with The Stock Day Podcast PressReach · Aug 1, 2022
BioCardia Announces First Canadian Clinical Site for CardiAMP Cell Therapy Heart Failure Trial PressReach · Aug 1, 2022
Tonix Pharmaceuticals Announces Issuance of U.S. Patent Covering Potentiated Intranasal Oxytocin (TNX-1900) for the Treatment of Pain PressReach · Aug 1, 2022
Evofem Announces Completion of Last Subject Last Visit (LSLV) in Registrational Phase 3 "EVOGUARD" Trial Evaluating Phexxi® for the Prevention of Chlamydia and Gonorrhea in Women PressReach · Aug 1, 2022
Cosmos Holdings Announces Agreement to Acquire Cana Laboratories, a Legacy European Pharmaceutical Company Established in 1928; Vertically Integrating its Manufacturing and R&D Capabilities and Expanding its Product Pipeline with New Brands PressReach · Jul 25, 2022
Soleno Therapeutics Provides Regulatory Update on DCCR for the Treatment of Prader-Willi Syndrome PressReach · Jul 25, 2022
